Detalles de la búsqueda
1.
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
Br J Haematol
; 200(3): 306-314, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261137
2.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320921
3.
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.
Ann Hematol
; 101(9): 2053-2067, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780254
4.
Rapid Colorimetric Detection of Wound Infection with a Fluidic Paper Device.
Int J Mol Sci
; 23(16)2022 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36012396
5.
Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study.
Br J Haematol
; 192(1): 82-99, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32426847
6.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol
; 189(1): 84-96, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702836
7.
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.
Ann Hematol
; 99(4): 799-808, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32076827
8.
Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(9): 1703-1712, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054983
9.
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Br J Haematol
; 184(5): 797-807, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548583
10.
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .
Biol Blood Marrow Transplant
; 24(5): 964-972, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29305194
11.
A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.
Am J Hematol
; 93(7): 867-873, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658143
12.
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.
Biol Blood Marrow Transplant
; 23(1): 53-59, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27771496
13.
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.
Biol Blood Marrow Transplant
; 23(10): 1631-1640, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533060
14.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Lancet
; 387(10020): 770-8, 2016 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26673811
15.
Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome.
Hematol Oncol
; 35(4): 520-527, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28156010
16.
Multifunctional Enzymatically Generated Hydrogels for Chronic Wound Application.
Biomacromolecules
; 18(5): 1544-1555, 2017 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28421746
17.
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.
Biol Blood Marrow Transplant
; 22(10): 1808-1815, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27470290
18.
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Biol Blood Marrow Transplant
; 22(3): 584-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26631751
19.
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
Br J Haematol
; 173(2): 245-52, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26847165
20.
Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.
Acta Haematol
; 136(2): 76-84, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27188649